These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15971886)

  • 1. [Effects of intravascular contrast media on urinary excretion of liver fatty acid-binding protein].
    Ohta S; Ishimitsu T; Minami J; Ono H; Matsuoka H
    Nihon Jinzo Gakkai Shi; 2005; 47(4):437-44. PubMed ID: 15971886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy.
    Nakamura T; Sugaya T; Node K; Ueda Y; Koide H
    Am J Kidney Dis; 2006 Mar; 47(3):439-44. PubMed ID: 16490622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy.
    Hofstra JM; Deegens JK; Steenbergen EJ; Wetzels JF
    Nephrol Dial Transplant; 2008 Oct; 23(10):3160-5. PubMed ID: 18403431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury.
    Manabe K; Kamihata H; Motohiro M; Senoo T; Yoshida S; Iwasaka T
    Eur J Clin Invest; 2012 May; 42(5):557-63. PubMed ID: 22070248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules.
    Kamijo A; Sugaya T; Hikawa A; Okada M; Okumura F; Yamanouchi M; Honda A; Okabe M; Fujino T; Hirata Y; Omata M; Kaneko R; Fujii H; Fukamizu A; Kimura K
    Am J Pathol; 2004 Oct; 165(4):1243-55. PubMed ID: 15466390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of liver fatty acid-binding protein in health-check participants.
    Ishimitsu T; Ohta S; Saito M; Teranishi M; Inada H; Yoshii M; Minami J; Ono H; Hikawa A; Shibata N; Sugaya T; Kamijo A; Kimura K; Ohrui M; Matsuoka H
    Clin Exp Nephrol; 2005 Mar; 9(1):34-9. PubMed ID: 15830271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [L-type fatty acid binding protein (L-FABP) and kidney disease].
    Kamijo-Ikemori A; Sugaya T; Kimura K
    Rinsho Byori; 2014 Feb; 62(2):163-70. PubMed ID: 24800492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary liver type fatty acid binding protein in diabetic nephropathy.
    Kamijo-Ikemori A; Sugaya T; Ichikawa D; Hoshino S; Matsui K; Yokoyama T; Yasuda T; Hirata K; Kimura K
    Clin Chim Acta; 2013 Sep; 424():104-8. PubMed ID: 23727660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney injury biomarkers after cardiac angiography in children with congenital heart disease.
    Nishida M; Kubo S; Morishita Y; Nishikawa K; Ikeda K; Itoi T; Hosoi H
    Congenit Heart Dis; 2019 Nov; 14(6):1087-1093. PubMed ID: 31605509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of L-type fatty acid binding protein in the urine of preterm neonates.
    Tsukahara H; Sugaya T; Hayakawa K; Mori Y; Hiraoka M; Hata A; Mayumi M
    Early Hum Dev; 2005 Jul; 81(7):643-6. PubMed ID: 15970406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary fatty acid binding protein in renal disease.
    Kamijo-Ikemori A; Sugaya T; Kimura K
    Clin Chim Acta; 2006 Dec; 374(1-2):1-7. PubMed ID: 16860300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of human liver type fatty acid binding protein in kidney disease clarified using hL-FABP chromosomal transgenic mice.
    Kamijo-Ikemori A; Sugaya T; Matsui K; Yokoyama T; Kimura K
    Nephrology (Carlton); 2011 Aug; 16(6):539-44. PubMed ID: 21504508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary lipocalin-type prostaglandin D synthase: a potential marker for early gentamicin-induced renal damage?
    Nakayama H; Echizen H; Gomi T; Shibuya Y; Nakamura Y; Nakano K; Arashi H; Itai T; Ohnishi S; Tanaka M; Orii T
    Ther Drug Monit; 2009 Feb; 31(1):126-30. PubMed ID: 19125150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contrast nephropathy with a non-ionic iodide medium in patients with normal and mildly impaired renal function].
    Usutani S
    Nihon Jinzo Gakkai Shi; 2000 May; 42(4):338-45. PubMed ID: 10897593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Urinary L-type fatty acid binding protein (L-FABP) as a new urinary biomarker promulgated by the Ministry of Health, Labour and Welfare in Japan].
    Kamijo-Ikemori A; Ichikawa D; Matsui K; Yokoyama T; Sugaya T; Kimura K
    Rinsho Byori; 2013 Jul; 61(7):635-40. PubMed ID: 24205707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pitavastatin on urinary liver-type fatty-acid-binding protein in patients with nondiabetic mild chronic kidney disease.
    Nakamura T; Sugaya T; Kawagoe Y; Suzuki T; Inoue T; Node K
    Am J Nephrol; 2006; 26(1):82-6. PubMed ID: 16534182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of red wine on urinary protein, 8-hydroxydeoxyguanosine, and liver-type fatty acid-binding protein excretion in patients with diabetic nephropathy.
    Nakamura T; Fujiwara N; Sugaya T; Ueda Y; Koide H
    Metabolism; 2009 Aug; 58(8):1185-90. PubMed ID: 19481229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary fatty acids and liver-type fatty acid binding protein in diabetic nephropathy.
    Sasaki H; Kamijo-Ikemori A; Sugaya T; Yamashita K; Yokoyama T; Koike J; Sato T; Yasuda T; Kimura K
    Nephron Clin Pract; 2009; 112(3):c148-56. PubMed ID: 19390215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion of liver-type fatty acid-binding protein as a marker of progressive kidney function deterioration in patients with chronic glomerulonephritis.
    Mou S; Wang Q; Li J; Shi B; Ni Z
    Clin Chim Acta; 2012 Jan; 413(1-2):187-91. PubMed ID: 21958699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infusion of radiocontrast agents induces exaggerated release of urinary endothelin in patients with impaired renal function.
    Fujisaki K; Kubo M; Masuda K; Tokumoto M; Hirakawa M; Ikeda H; Matsui R; Matsuo D; Fukuda K; Kanai H; Hirakata H; Iida M
    Clin Exp Nephrol; 2003 Dec; 7(4):279-83. PubMed ID: 14712357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.